Physician profile
Alexander Halstead
NPI 1689104499
$1,645.51
in general payments reported to CMS, 2019-2025
13 companies · $212 in 2025
The $212 reported for 2025 was more than what 90% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $128 · 2022: $63.60 · 2023: $710 · 2024: $531 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,453.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $408.99 | 2024-2025 | Hemosphere |
| Emd Serono, INC. | $254.51 | 2023-2024 | |
| Amgen INC. | $140.93 | 2024 | |
| Edwards Lifesciences Corporation | $127.11 | 2023 | |
| Horizon Therapeutics Plc | $124.99 | 2023 | Krystexxa |
| Abbvie INC. | $121.30 | 2023 | |
| Acacia Pharma INC | $112.71 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $101.22 | 2023 | Rexulti |
| Alexion Pharmaceuticals, INC. | $92.16 | 2023 | Soliris |
| Heron Therapeutics, INC. | $63.60 | 2022 | |
| Haemonetics Corporation | $60.02 | 2023-2024 | Teg6s Hemostasis System |
| Fisher & Paykel Healthcare INC | $22.20 | 2024 | Fisher & Paykel Healthcare |
| Avanos Medical | $15.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Halstead listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.